Transgene Biotek Q1 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
2.86
0.09 (3.25%)
0.09 (3.25%)Volume11.23 K
Updated: Thu 10 Sep, 2026 | 14:30:48
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹0.06 Cr.(21.21%)
- Operating Profit₹-0.10 Cr.(-47.13%)
- Profit After Tax₹-0.39 Cr.(-10.31%)
- Operating Margin-165.83%(-56.38%)
Note: Comparison is on YoY basis
Quarterly - Transgene Biotek Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.16 | 0.38 | -58.53% | 0.48 | -32.90% |
| Depreciation/ Amortization | 0.04 | 0.05 | -17.07% | 0.02 | -17.07% |
| Operating Income | -0.10 | -0.33 | -69.86% | -0.44 | -47.13% |
| Net Income | -0.39 | -0.46 | -14.88% | 0.20 | -10.31% |
| Other Operating Expenses Total | 0.08 | 0.30 | -71.93% | 0.38 | -39.94% |
| Net Income Before Taxes | -0.39 | -0.46 | -14.88% | 0.20 | -10.31% |
| Total Revenue | 0.06 | 0.05 | 10.09% | 0.05 | 21.21% |
| Selling/ General/ Admin Expenses Total | 0.03 | 0.03 | -0.30% | 0.08 | -28.60% |
| Diluted Normalized EPS | -0.05 | -0.06 | -16.67% | 0.03 | -16.67% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.